申请人:Abbott Laboratories
公开号:US05409946A1
公开(公告)日:1995-04-25
Novel isoxazole isothiazole and pyrazole compounds of the formula: ##STR1## wherein A, R.sup.1, and R.sup.2 are specifically defined, or pharmaceutical salts thereof, are selective and potent cholinergic ligands at neuronal nicotinic receptors, useful in the treatment of cognitive, neurological and mental disorders characterized by decreased cholinergic function, as well as in the treatment of alcohol intoxication and petit real absence epilepsy.
新型异噁唑、异噻唑和吡唑化合物的化学式为:##STR1## 其中A、R.sup.1和R.sup.2有明确定义,或其药物盐,是神经元乙酰胆碱受体的选择性和强效胆碱能配体,在治疗认知、神经和精神障碍中具有降低胆碱能功能的特征,以及在治疗酒精中毒和小发作性缺失性癫痫中有用。